Search Results for: RespireRx Pharmaceuticals Announces Publication of
Articles
November 29, 2021
RespireRx Pharmaceuticals Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury November 29, 2021
RespireRx Pharmaceuticals Inc. recently announced the publication by Dr. David Fuller (University of Florida) and his colleagues of two new,...
December 6, 2017
RespireRx Pharmaceuticals Announces Publication of Phase 2B PACE Study December 6, 2017
RespireRx Pharmaceuticals Inc. recently announced that the results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic Enhancement) clinical trial have...
